P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P18031 |
PTN1_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P18031 |
PTN1_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P18031 |
PTN1_HUMAN |
Obesity [ICD-11: 5B80-5B81] |
P18031 |
PTN1_HUMAN |
Ophthalmic devices/implants/grafts injury [ICD-11: PK97] |
P18031 |
PTN1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P18031 |
PTN1_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P18031 |
PTN1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P08575 |
PTPRC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P08575 |
PTPRC_HUMAN |
Transplanted organ/tissue [ICD-11: QB63] |
P08575 |
PTPRC_HUMAN |
Leukaemia [ICD-11: 2A60-2B33] |
P08575 |
PTPRC_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P08575 |
PTPRC_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P08575 |
PTPRC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P08575 |
PTPRC_HUMAN |
Transplant rejection [ICD-11: NE84] |
P08575 |
PTPRC_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P17706 |
PTN2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P23219 |
PGH1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P23219 |
PGH1_HUMAN |
Endometriosis [ICD-11: GA10] |
P23219 |
PGH1_HUMAN |
Eye anterior segment structural developmental anomaly [ICD-11: LA11] |
P23219 |
PGH1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P23219 |
PGH1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P23219 |
PGH1_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P23219 |
PGH1_HUMAN |
Nutritional deficiency [ICD-11: 5B50-5B71] |
P23219 |
PGH1_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P23219 |
PGH1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P23219 |
PGH1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P23219 |
PGH1_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P23219 |
PGH1_HUMAN |
Seborrhoeic dermatitis [ICD-11: EA81] |
P23219 |
PGH1_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P23219 |
PGH1_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P23219 |
PGH1_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P23219 |
PGH1_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P23219 |
PGH1_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P23219 |
PGH1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P23219 |
PGH1_HUMAN |
Systemic sclerosis [ICD-11: 4A42] |
P23219 |
PGH1_HUMAN |
Vasculitis [ICD-11: 4A44] |
P23219 |
PGH1_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
P23219 |
PGH1_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P23219 |
PGH1_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P23219 |
PGH1_HUMAN |
Fever [ICD-11: MG26] |
P23219 |
PGH1_HUMAN |
Gout [ICD-11: FA25] |
P23219 |
PGH1_HUMAN |
Sensation disturbance [ICD-11: MB40] |
P23219 |
PGH1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P23219 |
PGH1_HUMAN |
General pain disorder [ICD-11: 8E43] |
P23219 |
PGH1_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P23219 |
PGH1_HUMAN |
Endometriosis [ICD-11: GA10] |
P23219 |
PGH1_HUMAN |
Eye anterior segment structural developmental anomaly [ICD-11: LA11] |
P23219 |
PGH1_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P23219 |
PGH1_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P23219 |
PGH1_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P23219 |
PGH1_HUMAN |
Nutritional deficiency [ICD-11: 5B50-5B71] |
P23219 |
PGH1_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P23219 |
PGH1_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P23219 |
PGH1_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P23219 |
PGH1_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P23219 |
PGH1_HUMAN |
Seborrhoeic dermatitis [ICD-11: EA81] |
P23219 |
PGH1_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P23219 |
PGH1_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P23219 |
PGH1_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P23219 |
PGH1_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P23219 |
PGH1_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P23219 |
PGH1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P23219 |
PGH1_HUMAN |
Systemic sclerosis [ICD-11: 4A42] |
P23219 |
PGH1_HUMAN |
Vasculitis [ICD-11: 4A44] |
P23219 |
PGH1_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
P23219 |
PGH1_HUMAN |
Muscular dystrophy [ICD-11: 8C70] |
P23219 |
PGH1_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P23219 |
PGH1_HUMAN |
Fever [ICD-11: MG26] |
P23219 |
PGH1_HUMAN |
Gout [ICD-11: FA25] |
P23219 |
PGH1_HUMAN |
Sensation disturbance [ICD-11: MB40] |
P23219 |
PGH1_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P23219 |
PGH1_HUMAN |
General pain disorder [ICD-11: 8E43] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Liver cancer [ICD-11: 2C12] |
O75874 |
IDHC_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
O75874 |
IDHC_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
O75874 |
IDHC_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 |
PLK1_HUMAN |
Acute myeloid leukaemia [ICD-11: 2A60] |
P53350 |
PLK1_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P53350 |
PLK1_HUMAN |
Prostate cancer [ICD-11: 2C82] |
P53350 |
PLK1_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P53350 |
PLK1_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P53350 |
PLK1_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P53350 |
PLK1_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P53350 |
PLK1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q16236 |
NF2L2_HUMAN |
Ataxic disorder [ICD-11: 8A03] |
Q16236 |
NF2L2_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q16236 |
NF2L2_HUMAN |
Glaucoma [ICD-11: 9C61] |
Q16236 |
NF2L2_HUMAN |
Lung cancer [ICD-11: 2C25] |
Q16236 |
NF2L2_HUMAN |
Macular degeneration [ICD-11: 9B75] |
Q16236 |
NF2L2_HUMAN |
Melanoma [ICD-11: 2C30] |
Q16236 |
NF2L2_HUMAN |
Mental/behavioural/neurodevelopmental disorder [ICD-11: 6E20-6E8Z] |
Q16236 |
NF2L2_HUMAN |
Pulmonary hypertension [ICD-11: BB01] |
Q16236 |
NF2L2_HUMAN |
Subarachnoid haemorrhage [ICD-11: 8B01] |
Q16236 |
NF2L2_HUMAN |
Urinary system clinical sympton [ICD-11: MF8Y] |
Q16236 |
NF2L2_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q16236 |
NF2L2_HUMAN |
Alpha-1-antitrypsin deficiency [ICD-11: 5C5A] |
Q16236 |
NF2L2_HUMAN |
Motor neuron disease [ICD-11: 8B60] |
Q16236 |
NF2L2_HUMAN |
Multiple sclerosis [ICD-11: 8A40] |
P27695 |
APEX1_HUMAN |
Retinopathy [ICD-11: 9B71] |
P27695 |
APEX1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P27695 |
APEX1_HUMAN |
Ocular cancer [ICD-11: 2D00-2D07] |
P27695 |
APEX1_HUMAN |
Brain cancer [ICD-11: 2A00] |
P27695 |
APEX1_HUMAN |
Melanoma [ICD-11: 2C30] |
P11511 |
CP19A_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P11511 |
CP19A_HUMAN |
Cushing syndrome [ICD-11: 5A70] |
P11511 |
CP19A_HUMAN |
Oesophagitis [ICD-11: DA24] |
P11511 |
CP19A_HUMAN |
Endometriosis [ICD-11: GA10] |
P11511 |
CP19A_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P11511 |
CP19A_HUMAN |
Bladder cancer [ICD-11: 2C94] |
P11511 |
CP19A_HUMAN |
Prostate disease [ICD-11: GA91] |
P11597 |
CETP_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P11597 |
CETP_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P11597 |
CETP_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P11597 |
CETP_HUMAN |
Myocardial infarction [ICD-11: BA41-BA43] |
P11597 |
CETP_HUMAN |
Inborn lipid metabolism error [ICD-11: 5C52] |
P11597 |
CETP_HUMAN |
Chronic arterial occlusive disease [ICD-11: BD4Z] |
P11597 |
CETP_HUMAN |
Dyslipidemia [ICD-11: 5C80-5C81] |
P40763 |
STAT3_HUMAN |
Psoriasis [ICD-11: EA90] |
P40763 |
STAT3_HUMAN |
Brain cancer [ICD-11: 2A00] |
P40763 |
STAT3_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P40763 |
STAT3_HUMAN |
Liver cancer [ICD-11: 2C12] |
P40763 |
STAT3_HUMAN |
Malignant digestive organ neoplasm [ICD-11: 2C11] |
P40763 |
STAT3_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P40763 |
STAT3_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P40763 |
STAT3_HUMAN |
Respiratory infection [ICD-11: CA07-CA4Z] |
P40763 |
STAT3_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P40763 |
STAT3_HUMAN |
Immune system disease [ICD-11: 4A01-4B41] |
P40763 |
STAT3_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P40763 |
STAT3_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P40763 |
STAT3_HUMAN |
Multiple myeloma [ICD-11: 2A83] |
P40763 |
STAT3_HUMAN |
Mycosis fungoides [ICD-11: 2B01] |
P40763 |
STAT3_HUMAN |
Ulcerative colitis [ICD-11: DD71] |
P40763 |
STAT3_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P00533 |
EGFR_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P00533 |
EGFR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P00533 |
EGFR_HUMAN |
Angina pectoris [ICD-11: BA40] |
P00533 |
EGFR_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
P00533 |
EGFR_HUMAN |
Colon cancer [ICD-11: 2B90] |
P00533 |
EGFR_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P00533 |
EGFR_HUMAN |
Diabetic foot ulcer [ICD-11: BD54] |
P00533 |
EGFR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
P00533 |
EGFR_HUMAN |
Hepatitis virus infection [ICD-11: 1E50-1E51] |
P00533 |
EGFR_HUMAN |
Ischemia [ICD-11: 8B10-8B11] |
P00533 |
EGFR_HUMAN |
Liver cancer [ICD-11: 2C12] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Melanoma [ICD-11: 2C30] |
P00533 |
EGFR_HUMAN |
Myelodysplastic syndrome [ICD-11: 2A37] |
P00533 |
EGFR_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P00533 |
EGFR_HUMAN |
Renal cell carcinoma [ICD-11: 2C90] |
P00533 |
EGFR_HUMAN |
Skin postprocedural disorder [ICD-11: EL8Y] |
P00533 |
EGFR_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P00533 |
EGFR_HUMAN |
Stomach cancer [ICD-11: 2B72] |
P00533 |
EGFR_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
P00533 |
EGFR_HUMAN |
Urethral cancer [ICD-11: 2C93] |
P00533 |
EGFR_HUMAN |
Brain cancer [ICD-11: 2A00] |
P00533 |
EGFR_HUMAN |
Hypopharyngeal cancer [ICD-11: 2B6D] |
P00533 |
EGFR_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P00533 |
EGFR_HUMAN |
Metastatic biliary tract neoplasms [ICD-11: 2C14-2C17] |
P00533 |
EGFR_HUMAN |
Chronic pain [ICD-11: MG30] |
P00533 |
EGFR_HUMAN |
Lymphoma [ICD-11: 2A80-2A86] |
P00533 |
EGFR_HUMAN |
Malignant mesenchymal neoplasm [ICD-11: 2B5D-2B5Y] |
P00533 |
EGFR_HUMAN |
Non-small cell lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Intracerebral haemorrhage [ICD-11: 8B00] |
P00533 |
EGFR_HUMAN |
Mature B-cell leukaemia [ICD-11: 2A82] |
P00533 |
EGFR_HUMAN |
Metastatic lymph node neoplasm [ICD-11: 2D60] |
P00533 |
EGFR_HUMAN |
Spinal cord/cranial nerve neoplasm [ICD-11: 2A02] |
P00533 |
EGFR_HUMAN |
Testicular cancer [ICD-11: 2C80] |
P00533 |
EGFR_HUMAN |
Esophageal cancer [ICD-11: 2B70] |
P00533 |
EGFR_HUMAN |
Psoriasis [ICD-11: EA90] |
P00533 |
EGFR_HUMAN |
Digestive system disease [ICD-11: DE2Z] |
P00533 |
EGFR_HUMAN |
Cerebral ischaemia [ICD-11: 8B1Z] |
P00533 |
EGFR_HUMAN |
Cryptosporidiosis [ICD-11: 1A32] |
P00533 |
EGFR_HUMAN |
Diffuse large B-cell lymphoma [ICD-11: 2A81] |
P00533 |
EGFR_HUMAN |
Gram-positive bacterial infection [ICD-11: 1B74-1F40] |
P00533 |
EGFR_HUMAN |
Brain cancer [ICD-11: 2A00] |
P00533 |
EGFR_HUMAN |
Liver cancer [ICD-11: 2C12] |
P00533 |
EGFR_HUMAN |
Lung cancer [ICD-11: 2C25] |
P00533 |
EGFR_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P35354 |
PGH2_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P35354 |
PGH2_HUMAN |
Chronic pain [ICD-11: MG30] |
P35354 |
PGH2_HUMAN |
Endometriosis [ICD-11: GA10] |
P35354 |
PGH2_HUMAN |
Female pelvic pain [ICD-11: GA34] |
P35354 |
PGH2_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
P35354 |
PGH2_HUMAN |
Indeterminate colitis [ICD-11: DD72] |
P35354 |
PGH2_HUMAN |
Knee osteoarthritis [ICD-11: FA01] |
P35354 |
PGH2_HUMAN |
Migraine [ICD-11: 8A80] |
P35354 |
PGH2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35354 |
PGH2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35354 |
PGH2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35354 |
PGH2_HUMAN |
Tuberculosis [ICD-11: 1B10-1B12] |
P35354 |
PGH2_HUMAN |
Shoulder lesion [ICD-11: FB53] |
P35354 |
PGH2_HUMAN |
Soft tissue disorder [ICD-11: FB56] |
P35354 |
PGH2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35354 |
PGH2_HUMAN |
Asthma [ICD-11: CA23] |
P35354 |
PGH2_HUMAN |
Gout [ICD-11: FA25] |
P35354 |
PGH2_HUMAN |
General pain disorder [ICD-11: 8E43] |
P35354 |
PGH2_HUMAN |
Lupus erythematosus [ICD-11: 4A40] |
P35354 |
PGH2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P35354 |
PGH2_HUMAN |
Large intestine polyp [ICD-11: DB35] |
P35354 |
PGH2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P35354 |
PGH2_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P35354 |
PGH2_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
P35354 |
PGH2_HUMAN |
Colorectal cancer [ICD-11: 2B91] |
P35354 |
PGH2_HUMAN |
Fever [ICD-11: MG26] |
P35354 |
PGH2_HUMAN |
Malignant haematopoietic neoplasm [ICD-11: 2B33] |
P06746 |
DPOLB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06746 |
DPOLB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06746 |
DPOLB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06746 |
DPOLB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P06746 |
DPOLB_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q06124 |
PTN11_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q06124 |
PTN11_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P30305 |
MPIP2_HUMAN |
Lung cancer [ICD-11: 2C25] |
P30305 |
MPIP2_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P30305 |
MPIP2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P15121 |
ALDR_HUMAN |
Neuropathy [ICD-11: 8C0Z] |
P15121 |
ALDR_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P15121 |
ALDR_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P15121 |
ALDR_HUMAN |
Acute diabete complication [ICD-11: 5A2Y] |
P15121 |
ALDR_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P15121 |
ALDR_HUMAN |
Cataract [ICD-11: 9B10] |
P15121 |
ALDR_HUMAN |
Glaucoma [ICD-11: 9C61] |
P15121 |
ALDR_HUMAN |
Schizophrenia [ICD-11: 6A20] |
P15121 |
ALDR_HUMAN |
Gout [ICD-11: FA25] |
P15121 |
ALDR_HUMAN |
Head and neck cancer [ICD-11: 2D42] |
Q96RI1 |
NR1H4_HUMAN |
Autoimmune liver disease [ICD-11: DB96] |
Q96RI1 |
NR1H4_HUMAN |
Cholelithiasis [ICD-11: DC11] |
Q96RI1 |
NR1H4_HUMAN |
Insomnia [ICD-11: 7A00-7A0Z] |
Q96RI1 |
NR1H4_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
Q96RI1 |
NR1H4_HUMAN |
Breast cancer [ICD-11: 2C60-2C6Y] |
Q96RI1 |
NR1H4_HUMAN |
Non-alcoholic fatty liver disease [ICD-11: DB92] |
Q96RI1 |
NR1H4_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
Q96RI1 |
NR1H4_HUMAN |
Skeletal anomaly [ICD-11: LD24] |
Q96RI1 |
NR1H4_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q96RI1 |
NR1H4_HUMAN |
Hyper-lipoproteinaemia [ICD-11: 5C80] |
Q96RI1 |
NR1H4_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q99685 |
MGLL_HUMAN |
General pain disorder [ICD-11: 8E43] |
Q99685 |
MGLL_HUMAN |
Tic disorder [ICD-11: 8A05] |
P04054 |
PA21B_HUMAN |
Leishmaniasis [ICD-11: 1F54] |
P04054 |
PA21B_HUMAN |
Lichen planus [ICD-11: EA91] |
P04054 |
PA21B_HUMAN |
Peroxisomal disease [ICD-11: 5C57] |
P04054 |
PA21B_HUMAN |
Rosacea [ICD-11: ED90] |
P04054 |
PA21B_HUMAN |
Synthesis disorder [ICD-11: 5C52-5C59] |
P04054 |
PA21B_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P04054 |
PA21B_HUMAN |
Contact dermatitis [ICD-11: EK00-EK0Z] |
P04054 |
PA21B_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
P04054 |
PA21B_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P04054 |
PA21B_HUMAN |
Vasomotor/allergic rhinitis [ICD-11: CA08] |
P04054 |
PA21B_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P04054 |
PA21B_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P04054 |
PA21B_HUMAN |
Asthma [ICD-11: CA23] |
P04054 |
PA21B_HUMAN |
Pruritus [ICD-11: EC90] |
P04054 |
PA21B_HUMAN |
Unspecific body region injury [ICD-11: ND56] |
P04054 |
PA21B_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Filariasis [ICD-11: 1F66] |
P09917 |
LOX5_HUMAN |
Thrombocytopenia [ICD-11: 3B64] |
P09917 |
LOX5_HUMAN |
Lung cancer [ICD-11: 2C25] |
P09917 |
LOX5_HUMAN |
Nasopharyngeal cancer [ICD-11: 2B6B] |
P09917 |
LOX5_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P09917 |
LOX5_HUMAN |
Atopic eczema [ICD-11: EA80] |
P09917 |
LOX5_HUMAN |
Carcinoid syndrome [ICD-11: 5B10] |
P09917 |
LOX5_HUMAN |
Fungal infection [ICD-11: 1F29-1F2F] |
P09917 |
LOX5_HUMAN |
Idiopathic interstitial pneumonitis [ICD-11: CB03] |
P09917 |
LOX5_HUMAN |
Influenza [ICD-11: 1E30-1E32] |
P09917 |
LOX5_HUMAN |
Pituitary gland disorder [ICD-11: 5A60-5A61] |
P09917 |
LOX5_HUMAN |
Psoriasis [ICD-11: EA90] |
P09917 |
LOX5_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Respiratory system disease [ICD-11: CB40-CB7Z] |
P09917 |
LOX5_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P09917 |
LOX5_HUMAN |
Chronic obstructive pulmonary disease [ICD-11: CA22] |
P09917 |
LOX5_HUMAN |
Eczema [ICD-11: EA80-EA89] |
P09917 |
LOX5_HUMAN |
Pruritus [ICD-11: EC90] |
P09917 |
LOX5_HUMAN |
Thrombosis [ICD-11: DB61-GB90] |
P09917 |
LOX5_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P09917 |
LOX5_HUMAN |
Allergic/hypersensitivity disorder [ICD-11: 4A80-4A8Z] |
P09917 |
LOX5_HUMAN |
Arterial occlusive disease [ICD-11: BD40] |
P09917 |
LOX5_HUMAN |
Malaria [ICD-11: 1F40-1F45] |
P09917 |
LOX5_HUMAN |
Asthma [ICD-11: CA23] |
P09917 |
LOX5_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P09917 |
LOX5_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P05067 |
A4_HUMAN |
Diagnostic imaging [ICD-11: N.A.] |
P05067 |
A4_HUMAN |
Alzheimer disease [ICD-11: 8A20] |
P05067 |
A4_HUMAN |
Desmoid tumour [ICD-11: 2F7C] |
P05067 |
A4_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P05067 |
A4_HUMAN |
Retinopathy [ICD-11: 9B71] |
P05067 |
A4_HUMAN |
Dystrophic epidermolysis bullosa [ICD-11: EC32] |
P05067 |
A4_HUMAN |
Amyloidosis [ICD-11: 5D00] |
P05067 |
A4_HUMAN |
Macular degeneration [ICD-11: 9B75] |
P05067 |
A4_HUMAN |
Intracranial injury [ICD-11: NA07] |
P05067 |
A4_HUMAN |
Brain cancer [ICD-11: 2A00] |
P05067 |
A4_HUMAN |
Dissociative neurological symptom disorder [ICD-11: 6B60] |
P05067 |
A4_HUMAN |
Mild neurocognitive disorder [ICD-11: 6D71] |
P35228 |
NOS2_HUMAN |
Osteoarthritis [ICD-11: FA00-FA05] |
P35228 |
NOS2_HUMAN |
Sepsis [ICD-11: 1G40-1G41] |
P35228 |
NOS2_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
P35228 |
NOS2_HUMAN |
Chronic kidney disease [ICD-11: GB61] |
P35228 |
NOS2_HUMAN |
Asthma [ICD-11: CA23] |
P35228 |
NOS2_HUMAN |
Bowel habit change [ICD-11: ME05] |
P35228 |
NOS2_HUMAN |
Cardiovascular disease [ICD-11: BA00-BE2Z] |
P35228 |
NOS2_HUMAN |
Pain [ICD-11: MG30-MG3Z] |
P35228 |
NOS2_HUMAN |
Coronary atherosclerosis [ICD-11: BA80] |
P35228 |
NOS2_HUMAN |
Insulin-resistance syndrome [ICD-11: 5A44] |
P35228 |
NOS2_HUMAN |
Retinopathy [ICD-11: 9B71] |
P35228 |
NOS2_HUMAN |
Rheumatoid arthritis [ICD-11: FA20] |
P35228 |
NOS2_HUMAN |
Arteries/arterioles disorder [ICD-11: BD52] |
P35228 |
NOS2_HUMAN |
Postoperative inflammation [ICD-11: 1A00-CA43] |
P13726 |
TF_HUMAN |
Acute respiratory distress syndrome [ICD-11: CB00] |
P13726 |
TF_HUMAN |
Bleeding disorder [ICD-11: GA20-GA21] |
P13726 |
TF_HUMAN |
Pancreatic cancer [ICD-11: 2C10] |
P13726 |
TF_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |
Q8TDU6 |
GPBAR_HUMAN |
Type 2 diabetes mellitus [ICD-11: 5A11] |
Q8TDU6 |
GPBAR_HUMAN |
Hepatic fibrosis/cirrhosis [ICD-11: DB93] |
Q8TDU6 |
GPBAR_HUMAN |
Metabolic disorder [ICD-11: 5C50-5D2Z] |
Q96KS0 |
EGLN2_HUMAN |
Acute disease anaemia [ICD-11: 3A90] |
Q96KS0 |
EGLN2_HUMAN |
Autism spectrum disorder [ICD-11: 6A02] |
Q96KS0 |
EGLN2_HUMAN |
Diabetic foot ulcer [ICD-11: BD54] |
Q96KS0 |
EGLN2_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
Q96KS0 |
EGLN2_HUMAN |
Anemia [ICD-11: 3A00-3A9Z] |
Q9GZT9 |
EGLN1_HUMAN |
Acute disease anaemia [ICD-11: 3A90] |
Q9GZT9 |
EGLN1_HUMAN |
Urinary system disease [ICD-11: GC2Z] |
Q9GZT9 |
EGLN1_HUMAN |
Solid tumour/cancer [ICD-11: 2A00-2F9Z] |